These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7869618)

  • 1. Characterization of acetylcholinesterase-inhibition by itopride.
    Iwanaga Y; Kimura T; Miyashita N; Morikawa K; Nagata O; Itoh Z; Kondo Y
    Jpn J Pharmacol; 1994 Nov; 66(3):317-22. PubMed ID: 7869618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acotiamide Hydrochloride, a Therapeutic Agent for Functional Dyspepsia, Enhances Acetylcholine-induced Contraction via Inhibition of Acetylcholinesterase Activity in Circular Muscle Strips of Guinea Pig Stomach.
    Ito K; Kawachi M; Matsunaga Y; Hori Y; Ozaki T; Nagahama K; Hirayama M; Kawabata Y; Shiraishi Y; Takei M; Tanaka T
    Drug Res (Stuttg); 2016 Apr; 66(4):196-202. PubMed ID: 26418413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of KW-5092, a novel gastroprokinetic agent, on the activity of acetylcholinesterase in guinea pig ileum.
    Kishibayashi N; Ishii A; Karasawa A
    Jpn J Pharmacol; 1994 Dec; 66(4):397-403. PubMed ID: 7723214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of itopride hydrochloride on the ileal and colonic motility in guinea pig in vitro.
    Lim HC; Kim YG; Lim JH; Kim HS; Park H
    Yonsei Med J; 2008 Jun; 49(3):472-8. PubMed ID: 18581598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acotiamide hydrochloride (Z-338), a new selective acetylcholinesterase inhibitor, enhances gastric motility without prolonging QT interval in dogs: comparison with cisapride, itopride, and mosapride.
    Matsunaga Y; Tanaka T; Yoshinaga K; Ueki S; Hori Y; Eta R; Kawabata Y; Yoshii K; Yoshida K; Matsumura T; Furuta S; Takei M; Tack J; Itoh Z
    J Pharmacol Exp Ther; 2011 Mar; 336(3):791-800. PubMed ID: 21123674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastroprokinetic effect of a new benzamide derivative itopride and its action mechanisms in conscious dogs.
    Iwanaga Y; Miyashita N; Saito T; Morikawa K; Itoh Z
    Jpn J Pharmacol; 1996 Jun; 71(2):129-37. PubMed ID: 8835639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation by cholinesterase inhibitors of cholinergic activity in rat isolated stomach and colon.
    Jarvie EM; Cellek S; Sanger GJ
    Pharmacol Res; 2008; 58(5-6):297-301. PubMed ID: 18824231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acotiamide hydrochloride (Z-338) enhances gastric motility and emptying by inhibiting acetylcholinesterase activity in rats.
    Kawachi M; Matsunaga Y; Tanaka T; Hori Y; Ito K; Nagahama K; Ozaki T; Inoue N; Toda R; Yoshii K; Hirayama M; Kawabata Y; Takei M
    Eur J Pharmacol; 2011 Sep; 666(1-3):218-25. PubMed ID: 21651906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro protection of acetylcholinesterase and butyrylcholinesterase by tetrahydroaminoacridine. Comparison with physostigmine.
    Galli A; Mori F; Gori I; Lucherini M
    Biochem Pharmacol; 1992 Jun; 43(11):2427-33. PubMed ID: 1610407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acotiamide, a new orally active acetylcholinesterase inhibitor, stimulates gastrointestinal motor activity in conscious dogs.
    Nagahama K; Matsunaga Y; Kawachi M; Ito K; Tanaka T; Hori Y; Oka H; Takei M
    Neurogastroenterol Motil; 2012 Jun; 24(6):566-74, e256. PubMed ID: 22429221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of cholinesterase-associated aryl acylamidase activity by anticholinesterase agents: focus on drugs potentially effective in Alzheimer's disease.
    Costagli C; Galli A
    Biochem Pharmacol; 1998 May; 55(10):1733-7. PubMed ID: 9634011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species- and concentration-dependent differences of acetyl- and butyrylcholinesterase sensitivity to physostigmine and neostigmine.
    Bitzinger DI; Gruber M; Tümmler S; Michels B; Bundscherer A; Hopf S; Trabold B; Graf BM; Zausig YA
    Neuropharmacology; 2016 Oct; 109():1-6. PubMed ID: 26772968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro and in-vivo protection of acetylcholinesterase by eseroline against inactivation by diisopropyl fluorophosphate and carbamates.
    Galli A; Malmberg Aiello P; Renzi G; Bartolini A
    J Pharm Pharmacol; 1985 Jan; 37(1):42-8. PubMed ID: 2858526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of HSR-803 on gastrointestinal motility].
    Iwanaga H; Miyashita N; Kondo Y; Mizumoto A; Ito A
    Nihon Heikatsukin Gakkai Zasshi; 1989 Dec; 25(6):313-5. PubMed ID: 2702276
    [No Abstract]   [Full Text] [Related]  

  • 15. Indirect parasympathomimetic activity of metoclopramide: reversible inhibition of cholinesterases from human central nervous system and blood.
    Chemnitius JM; Haselmeyer KH; Gonska BD; Kreuzer H; Zech R
    Pharmacol Res; 1996; 34(1-2):65-72. PubMed ID: 8981558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of 2-imidazolidinylidenepropanedinitrile derivatives as stimulators of gastrointestinal motility.
    Sasho S; Obase H; Ichikawa S; Kitazawa T; Nonaka H; Yoshizaki R; Ishii A; Shuto K
    J Med Chem; 1993 Mar; 36(5):572-9. PubMed ID: 8496937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphoacetylcholinesterase: toxicity of phosphorus oxychloride to mammals and insects that can be attributed to selective phosphorylation of acetylcholinesterase by phosphorodichloridic acid.
    Quistad GB; Zhang N; Sparks SE; Casida JE
    Chem Res Toxicol; 2000 Jul; 13(7):652-7. PubMed ID: 10898598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of cholinesterases in rat urinary bladder contractility.
    Nakahara T; Kubota Y; Sakamoto K; Ishii K
    Urol Res; 2003 Jul; 31(3):223-6. PubMed ID: 12736766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of itopride hydrochloride on the delayed rectifier K+ and L-type CA2+ currents in guinea-pig ventricular myocytes.
    Morisawa T; Hasegawa J; Hama R; Kitano M; Kishimoto Y; Kawasaki H
    Res Commun Mol Pathol Pharmacol; 1999; 106(1-2):37-45. PubMed ID: 11127807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastroprokinetic activity of nizatidine, a new H2-receptor antagonist, and its possible mechanism of action in dogs and rats.
    Ueki S; Seiki M; Yoneta T; Aita H; Chaki K; Hori Y; Morita H; Tagashira E; Itoh Z
    J Pharmacol Exp Ther; 1993 Jan; 264(1):152-7. PubMed ID: 8093722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.